Engineers at the forefront,

Patients at the center.

Omnia Medical’s innovative implants set a new standard in surgical practice and patient outcomes. Our results speak for themselves. Patients and physicians agree – Omnia works for all.

For Pain Patients

For Physicians

Our Solutions

Posterior Allograft SI Fusion

PsiF →

Posterior SI Procedure Kit

PsiF90 →

Dynamic SI Guidance

PsiFGuard →

Standalone ALIF IBD

TiBrid SA →

Vertebral Body Replacement

Boxcar →

Demineralized Bone Matrix

DBLogix →

Allogenic Bone Scaffold

CeLLogix →

Rotatable IBD

Rotary →

About Omnia Medical

Revolutionizing healthcare. Optimizing patient outcomes. These are the founding principles of Omnia Medical. Our cutting-edge implants are at the forefront of advanced medical care, empowering surgeons to practice to their full potential and provide exceptional patient care.

Learn more

Trusted by the Best

Latest News & Events

Featured

Omnia Medical Reaches Settlement as PainTEQ Admits Breach and Patent Infringement

After several years of litigation, Omnia and PainTEQ have fully and finally resolved all of the issues between them. As part of that resolution PainTEQ agreed to admit that it breached the parties’ Stocking Agreement, used Omnia’s PsiF trademark, and that PainTEQ’s Gen 2 cannula infringed Omnia’s D232 design patent.

Omnia Files Response in Opposition to PainTEQ’s Motion for Summary Judgment

Relying heavily on testimony provided during the sworn depositions of Sean LaNeve, Chris Girsch, and Charles Girsch, as well as corporate representatives of RTI and Avalign, Omnia gave a glimpse into some of the many facts and arguments it intends to use during trial, which is currently set for October 7, 2024.

Omnia Challenges PainTEQ Intellectual Property

Omnia Medical, a medical device company committed to providing the industry with innovative solutions utilizing proven techniques, announced that the Patent Trial and Appeal Board (PTAB) of the US Patent and Trademark Office on Thursday September 20th granted institution in IPR2023-00625.